School of Public Health, Hebei Medical University, Shijiazhuang 050017, China.
Hebei Qianye Biotechnology Co, Shijiazhuang 050000, China.
J Chromatogr A. 2024 Aug 2;1728:465019. doi: 10.1016/j.chroma.2024.465019. Epub 2024 May 23.
A stable isotope dilution-liquid chromatography-tandem mass spectrometry method based on a derivatisation strategy involving an N,N'-carbonylimidazole solution (CDI) with 4-(dimethylamino)-benzenemethanamine was developed for the determination of 11 free fatty acids (FFAs) in human blood samples. Serum samples were subjected to liquid‒liquid extraction and centrifuged, and the supernatant was collected for a two-step derivatisation reaction with a CDI and 4-(dimethylamino)-aniline acetonitrile solution. The derivatised solution was separated on a ACQUITY UPLC HSS T3 column (2.1 × 50 mm, 1.8 µm) column with a mobile phase consisting of water-acetonitrile in gradient elution and then detected by tandem mass spectrometry using electrospray ionisation (ESI) and multiple reaction monitoring (MRM) in positive ion mode and quantified using the isotope internal standard method. The effects of the derivatisation reaction time, temperature and concentration of derivatisation reagents on the response values of the analytes were investigated. The optimal conditions were as follows: 1.0 mg mL CDI acetonitrile solution at 25 °C for 25 min, followed by a reaction with a 1.0 mg mL 4-(dimethylamino)-benzenemethanamine acetonitrile solution at 70 °C for 30 min. Under the optimal conditions, the limits of detection (LODs) of the 11 FFAs were in the range of 3.0-14.0 ng mL; the limits of quantification (LOQs) were in the range of 8.0-45.0 ng mL; and the mean recoveries ranged from 83.4 to 112.8%, with intraday and interday precisions ranging from 0.7 to 9.1% and 3.7-9.5%, respectively. The experimental method is simple in terms of the pretreatment operation, accurate and reliable, and can be applied to the sensitive determination of FFAs in human blood samples.
建立了一种基于衍生化策略的稳定同位素稀释-液相色谱-串联质谱法,该策略涉及 N,N'-羰基咪唑溶液(CDI)与 4-(二甲基氨基)-苯甲胺的反应。该方法用于测定人血样中的 11 种游离脂肪酸(FFAs)。血清样品经液-液萃取和离心后,收集上清液进行两步衍生化反应,分别用 CDI 和 4-(二甲基氨基)-苯胺乙腈溶液进行衍生化反应。衍生化溶液在 ACQUITY UPLC HSS T3 柱(2.1×50mm,1.8µm)上进行分离,流动相由水-乙腈组成,采用梯度洗脱,然后通过电喷雾电离(ESI)和正离子模式下的多反应监测(MRM)进行串联质谱检测,并采用同位素内标法进行定量。考察了衍生化反应时间、温度和衍生化试剂浓度对分析物响应值的影响。优化条件为:1.0mg·mL-1 CDI 乙腈溶液 25℃衍生化 25min,再与 1.0mg·mL-1 4-(二甲基氨基)-苯甲胺乙腈溶液 70℃衍生化 30min。在最佳条件下,11 种 FFA 的检出限(LOD)范围为 3.0-14.0ng·mL-1;定量限(LOQ)范围为 8.0-45.0ng·mL-1;平均回收率在 83.4%-112.8%之间,日内和日间精密度分别在 0.7%-9.1%和 3.7%-9.5%之间。该实验方法预处理操作简单,准确可靠,可用于人血样中 FFA 的灵敏测定。